Behavioral
Nasal High Flow Therapy
Nasal High Flow Therapy is a behavioral intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Nasal High-Flow in COPD
NCT03564236
completednot_applicable
Exploratory Study on Therapy for Breath Hold in Radiotherapy
NCT03729661
completednot_applicable
The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure
NCT02804243
Clinical Trials (3)
Showing 3 of 3 trials
NCT03564236Not Applicable
Nasal High-Flow in COPD
NCT03729661Not Applicable
Exploratory Study on Therapy for Breath Hold in Radiotherapy
NCT02804243Not Applicable
The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure
All 3 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 3